rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Anne Altmeyer

Director

Company insider

Files Form 4 as: Director, Corbus Pharmaceuticals Holdings.

Every Form 4 they filed

In numbers

Trades disclosed
16
Buys
0
Sells
3
Bought
$0
Sold
$70K
Companies
1
Companies where not an officer
1
First trade
26 Sep 2022
Last trade
10 Jun 2026
Last filed
11 Jun 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
CRBP Corbus Pharmaceuticals HoldingsDirector · Biotechnology · last 10 Jun 20260 buys · 3 sells

Activity over time

1 May 2025 – 1 Oct 2026
10May 25Sep 25Feb 26Jun 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
10 Jun 2026filed 11 Jun 2026CRBP Corbus Pharmaceuticals HoldingsBiotechnologySEC FORM 4 Sold$19K2,412 at $7.91filing
10 Jun 2026filed 11 Jun 2026CRBP Corbus Pharmaceuticals HoldingsBiotechnologySEC FORM 4 Sold$19K2,412 at $7.91filing
19 May 2026filed 21 May 2026CRBP Corbus Pharmaceuticals HoldingsBiotechnologySEC FORM 4 Code A—3,800 at $0.00filing
19 May 2026filed 21 May 2026CRBP Corbus Pharmaceuticals Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—12,300 at $0.00filing
19 May 2026filed 21 May 2026CRBP Corbus Pharmaceuticals Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—12,300 at $0.00filing
19 May 2026filed 21 May 2026CRBP Corbus Pharmaceuticals HoldingsBiotechnologySEC FORM 4 Code A—3,800 at $0.00filing
20 Oct 2025filed 21 Oct 2025CRBP Corbus Pharmaceuticals Holdingsoption or derivative · BiotechnologySEC FORM 4 Code M—1,060 at $0.00filing
20 Oct 2025filed 21 Oct 2025CRBP Corbus Pharmaceuticals HoldingsBiotechnologySEC FORM 4 Code M$5,0881,060 at $4.80filing
20 Oct 2025filed 21 Oct 2025CRBP Corbus Pharmaceuticals HoldingsBiotechnologySEC FORM 4 Sold$22K1,060 at $20.50filing
30 May 2025filed 2 Jun 2025CRBP Corbus Pharmaceuticals Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—16,000 at $0.00filing
30 May 2025filed 2 Jun 2025CRBP Corbus Pharmaceuticals HoldingsBiotechnologySEC FORM 4 Sold$10K1,392 at $7.25filing
30 May 2025filed 2 Jun 2025CRBP Corbus Pharmaceuticals HoldingsBiotechnologySEC FORM 4 Code A—4,800 at $0.00filing
30 May 2024filed 3 Jun 2024CRBP Corbus Pharmaceuticals HoldingsBiotechnologySEC FORM 4 Code A—2,783 at $0.00filing
16 May 2024filed 20 May 2024CRBP Corbus Pharmaceuticals Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—2,783 at $0.00filing
18 May 2023filed 22 May 2023CRBP Corbus Pharmaceuticals Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—5,300 at $0.00filing
26 Sep 2022filed 28 Sep 2022CRBP Corbus Pharmaceuticals Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—159,200 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care3

Buys in green, sells in red, by the company’s sector.

Related people

Yong BenChief Med & Dev Officer · Director at Corbus Pharmaceuticals Holdings, filing Form 4 there in the last year
Leonardo Viana NicacioChief Medical Officer · Chief Medical Officer at Corbus Pharmaceuticals Holdings, filing Form 4 there in the last year
Nishant C. SaxenaChief Business Officer · Chief Business Officer at Corbus Pharmaceuticals Holdings, filing Form 4 there in the last year
Sean F. MoranChief Financial Officer · Chief Financial Officer at Corbus Pharmaceuticals Holdings, filing Form 4 there in the last year
Yuval CohenChief Executive Officer · Chief Executive Officer at Corbus Pharmaceuticals Holdings, filing Form 4 there in the last year